3 results
Approved WMOCompleted
OX40 agonists have been shown to increase antitumor immunity and improve tumor-free survival in non-clinical models and OX40 agonist monoclonal antibodies (mAbs) are currently being evaluated in Phase I clinical trials. GSK3174998 is a humanized…
Approved WMOWill not start
The primary objective of this study is to improve asthma control in adults with difficult to treat asthma, by increasing therapy adherence and inhalation technique with qualitative feedback.
Approved WMORecruiting
The primary objective of this study is to improve asthma control in children with asthma by trying to improve therapy adherence and inhalation technique by providing them with qualitative feedback after their inhalation. This can be seen by the…